Literature DB >> 16527542

Interferon gamma: a crucial role in the function of induced regulatory T cells in vivo.

Kathryn J Wood1, Birgit Sawitzki.   

Abstract

Interferon (IFN)gamma can have paradoxical functions, eliciting inflammatory T helper 1 (Th1)-driven immune responses in some circumstances, and enabling induced regulatory T (Treg) cells to control immune responses in others. Here, we propose a model in which IFNgamma produced rapidly and only transiently by induced Treg cells is crucial to their function in vivo. This early production of IFNgamma by induced Treg cells during an immune response can directly inhibit the activation and proliferation of IFNgammaR1- and IFNgammaR2-bearing T cells. Furthermore, it can indirectly prevent further T-cell activation by creating a microenvironment that influences the function of antigen-presenting cells (APCs) as a result of IFNgamma-induced inducible nitric oxide synthase (iNOS), indoleamine-2,3-dioxygenase (IDO) and heme oxygenase (HO)-1 expression.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16527542     DOI: 10.1016/j.it.2006.02.008

Source DB:  PubMed          Journal:  Trends Immunol        ISSN: 1471-4906            Impact factor:   16.687


  51 in total

1.  Nitric oxide controls an inflammatory-like Ly6C(hi)PDCA1+ DC subset that regulates Th1 immune responses.

Authors:  Daniela Giordano; Chang Li; Mehul S Suthar; Kevin E Draves; Daphne Y Ma; Michael Gale; Edward A Clark
Journal:  J Leukoc Biol       Date:  2010-12-22       Impact factor: 4.962

2.  Molecular mechanisms of induction of antigen-specific allograft tolerance by intranasal peptide administration.

Authors:  Katy Derbyshire; Caroline Addey; David Coe; Daniel W Stuckey; Hasan Muezzin; Jason A Bubier; Daniel J Shaffer; Derry C Roopenian; Jian-Guo Chai; Diane M Scott
Journal:  J Immunol       Date:  2011-04-13       Impact factor: 5.422

Review 3.  Regulating the regulators: costimulatory signals control the homeostasis and function of regulatory T cells.

Authors:  Hélène Bour-Jordan; Jeffrey A Bluestone
Journal:  Immunol Rev       Date:  2009-05       Impact factor: 12.988

Review 4.  Mechanisms of hepatic ischemia-reperfusion injury and protective effects of nitric oxide.

Authors:  Lian-Yue Guan; Pei-Yao Fu; Pei-Dong Li; Zhuo-Nan Li; Hong-Yu Liu; Min-Gang Xin; Wei Li
Journal:  World J Gastrointest Surg       Date:  2014-07-27

5.  The calcineurin inhibitor tacrolimus allows the induction of functional CD4CD25 regulatory T cells by rabbit anti-thymocyte globulins.

Authors:  V D K D Sewgobind; L J W van der Laan; M M L Kho; R Kraaijeveld; S S Korevaar; W Mol; W Weimar; C C Baan
Journal:  Clin Exp Immunol       Date:  2010-05-28       Impact factor: 4.330

6.  CD4+CD25+ regulatory T cells have divergent effects on intestinal inflammation in IL-10 gene-deficient mice.

Authors:  Beate C Sydora; Sarah M MacFarlane; Michele M Tavernini; Jason S G Doyle; Richard N Fedorak
Journal:  Dig Dis Sci       Date:  2008-06       Impact factor: 3.199

Review 7.  Immunomodulation of autoimmune arthritis by pro-inflammatory cytokines.

Authors:  Eugene Y Kim; Kamal D Moudgil
Journal:  Cytokine       Date:  2017-04-25       Impact factor: 3.861

8.  Tolerance induction or sensitization in mice exposed to noninherited maternal antigens (NIMA).

Authors:  M L Molitor-Dart; J Andrassy; L D Haynes; W J Burlingham
Journal:  Am J Transplant       Date:  2008-11       Impact factor: 8.086

9.  IL-12hi rapamycin-conditioned dendritic cells mediate IFN-γ-dependent apoptosis of alloreactive CD4+ T cells in vitro and reduce lethal graft-versus-host disease.

Authors:  Elizabeth O Stenger; Brian R Rosborough; Lisa R Mathews; Huihui Ma; Markus Y Mapara; Angus W Thomson; Hēth R Turnquist
Journal:  Biol Blood Marrow Transplant       Date:  2013-11-12       Impact factor: 5.742

10.  IL-12R beta 2 promotes the development of CD4+CD25+ regulatory T cells.

Authors:  Zhao Zhao; Shuo Yu; Denise C Fitzgerald; Mohamed Elbehi; Bogoljub Ciric; A M Rostami; Guang-Xian Zhang
Journal:  J Immunol       Date:  2008-09-15       Impact factor: 5.422

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.